Vascular endothelial cells: heterogeneity and targeting approaches
Forming the inner layer of the vascular system, endothelial cells (ECs) facilitate a multitude
of crucial physiological processes throughout the body. Vascular ECs enable the vessel wall …
of crucial physiological processes throughout the body. Vascular ECs enable the vessel wall …
Targeting the blood-brain barrier for the delivery of stroke therapies
A variety of neuroprotectants have shown promise in treating ischemic stroke, yet their
delivery to the brain remains a challenge. The endothelial cells lining the blood-brain barrier …
delivery to the brain remains a challenge. The endothelial cells lining the blood-brain barrier …
The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells
J Wenzel, J Lampe, H Müller-Fielitz, R Schuster… - Nature …, 2021 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) can damage cerebral small vessels and
cause neurological symptoms. Here we describe structural changes in cerebral small …
cause neurological symptoms. Here we describe structural changes in cerebral small …
Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier
OA Marcos-Contreras, CF Greineder… - Proceedings of the …, 2020 - National Acad Sciences
Drug targeting to inflammatory brain pathologies such as stroke and traumatic brain injury
remains an elusive goal. Using a mouse model of acute brain inflammation induced by local …
remains an elusive goal. Using a mouse model of acute brain inflammation induced by local …
Antigen recognition detains CD8+ T cells at the blood-brain barrier and contributes to its breakdown
S Aydin, J Pareja, VM Schallenberg, A Klopstein… - Nature …, 2023 - nature.com
Blood-brain barrier (BBB) breakdown and immune cell infiltration into the central nervous
system (CNS) are early hallmarks of multiple sclerosis (MS). High numbers of CD8+ T cells …
system (CNS) are early hallmarks of multiple sclerosis (MS). High numbers of CD8+ T cells …
ANKS1A regulates LDL receptor-related protein 1 (LRP1)-mediated cerebrovascular clearance in brain endothelial cells
J Lee, H Lee, H Lee, M Shin, MG Shin, J Seo… - Nature …, 2023 - nature.com
Brain endothelial LDL receptor-related protein 1 (LRP1) is involved in the clearance of Aβ
peptides across the blood-brain barrier (BBB). Here we show that endothelial deficiency of …
peptides across the blood-brain barrier (BBB). Here we show that endothelial deficiency of …
NF-κB pathway and the Goldilocks principle: Lessons from human disorders of immunity and inflammation
O Scott, CM Roifman - Journal of Allergy and Clinical Immunology, 2019 - Elsevier
Nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signaling pathways play a
key role in various cell processes related to host immunity. The last few years have seen an …
key role in various cell processes related to host immunity. The last few years have seen an …
A novel strategy for delivering N iemann‐P ick type C2 proteins across the blood–brain barrier using the brain endothelial‐specific AAV‐BR1 virus
CLM Rasmussen, E Hede, LJ Routhe… - Journal of …, 2023 - Wiley Online Library
Treating central nervous system (CNS) diseases is complicated by the incapability of
numerous therapeutics to cross the blood–brain barrier (BBB), mainly composed of brain …
numerous therapeutics to cross the blood–brain barrier (BBB), mainly composed of brain …
Uncovering incontinentia pigmenti: from DNA sequence to pathophysiology
KN How, HJY Leong, ZAD Pramono, KF Leong… - Frontiers in …, 2022 - frontiersin.org
Incontinentia pigmenti (IP) is an X-linked dominant genodermatosis. The disease is known
to be caused by recurrent deletion of exons 4–10 of the Inhibitor Of Nuclear Factor Kappa B …
to be caused by recurrent deletion of exons 4–10 of the Inhibitor Of Nuclear Factor Kappa B …
Brain endothelial specific gene therapy improves experimental Sandhoff disease
G Dogbevia, H Grasshoff, A Othman… - Journal of Cerebral …, 2020 - journals.sagepub.com
In Tay-Sachs and Sandhoff disease, a deficiency of the lysosomal enzyme β-
hexosaminidase causes GM2 and other gangliosides to accumulate in neurons and triggers …
hexosaminidase causes GM2 and other gangliosides to accumulate in neurons and triggers …